Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-02-25
    E.g., 2018-02-25

Articles

11899 items
5:47 PM, Feb 07, 2018  |  BC Extra | Financial News

Biotech indexes mixed

Biotech indexes were mixed on Wednesday in the wake of Tuesday’s gains, as the NASDAQ Biotechnology Index (NBI) finished up 0.07% and NYSE Arca Biotechnology Index (BTK) slipped 0.38%. The BioCentury 100 finished up 0.14%....
4:05 PM, Feb 07, 2018  |  BC Extra | Financial News

Atlas Venture, ShangBay Capital add venture partners

Atlas Venture said Nessan Bermingham has rejoined the VC firm as venture partner. Bermingham was CEO of Intellia Therapeutics Inc. (NASDAQ:NTLA), which he co-founded with Atlas in 2014. VC firm ShangBay Capital appointed Erik Engelson as...
3:47 PM, Feb 07, 2018  |  BC Extra | Financial News

CRISPR stocks up on Gilead's gene editing interest

CRISPR-based stocks made gains Wednesday after Gilead Sciences Inc. (NASDAQ:GILD) said in its 4Q17 earnings late Tuesday that it was pursuing deals in gene editing (see BioCentury Extra, Feb. 6). CRISPR Therapeutics AG (NASDAQ:CRSP) added $5.11...
4:22 PM, Feb 06, 2018  |  BC Extra | Financial News

NEA leads Xoc's $30M series A

CNS disease company Xoc Pharmaceuticals Inc. (Los Gatos, Calif.) closed a tranched $30 million series A round led by New Enterprise Associates. Details regarding the round's tranches are not disclosed. Xoc spokesperson Lisa Borland told BioCentury...
3:09 PM, Feb 06, 2018  |  BC Extra | Financial News

EdRIP unveils new €345 million fund

Edmond de Rothschild Investment Partners closed its fifth fund, BioDiscovery 5, at €345 million ($428 million), one of the largest European VC funds focused on life sciences ever, according to BioCentury’s BCIQ database. The fund...
2:47 PM, Feb 06, 2018  |  BC Extra | Financial News

Turbulence in U.S. markets spreads to rest of world

While U.S. stocks made gains on Tuesday, shocks from Monday's sell-off reverberated in markets around the globe. On Tuesday, the Financial Times Stock Exchange 100 Index (FTSE 100) in London fell 2.6%, while the Nikkei 225...
9:57 AM, Feb 06, 2018  |  BC Extra | Financial News

Chinese derma-aesthetic company Luqa raises $15M

Luqa Pharmaceuticals (Hong Kong, China) raised $15 million in a series B round led by Cenova Capital. The company markets derma-aesthetic and other specialty products in China. Cenova founder and chairman Jun Wu joined Luqa’s board. Morningside...
3:34 PM, Feb 05, 2018  |  BC Extra | Financial News

Biotech dips amid market sell-off

On Monday, biotech indices traded in line with the broader markets, which saw a sell-off largely driven by concerns over rising interest rates. The Dow Jones Industrial Average (DJIA) dropped 5% on the day, while the...
4:38 PM, Feb 01, 2018  |  BC Extra | Financial News

Partner Therapeutics raises $60M, in-licenses Leukine

Newco Partner Therapeutics Inc. (Boston, Mass.) raised $60 million on Thursday in a series A round led by Perceptive Advisors and also gained rights to Leukine sargramostim from Sanofi (Euronext:SAN; NYSE:SNY). Fellow new investors Adams...
1:29 PM, Feb 01, 2018  |  BC Extra | Financial News

mRNA play Moderna raises $500M series G

Moderna Therapeutics Inc. (Cambridge, Mass.) raised $500 million in an untranched series G round. New investors included an Abu Dhabi Investment Authority subsidiary, BB Biotech AG (SIX:BION; Xetra:BBZA), Julius Baer, EDBI and Sequoia Capital China....

Pages